Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of... – Method of regulating cell metabolism or physiology
Reexamination Certificate
2005-02-08
2005-02-08
LeGuyader, John L. (Department: 1635)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
Method of regulating cell metabolism or physiology
C435S006120, C435S325000, C536S023100, C536S024500
Reexamination Certificate
active
06852536
ABSTRACT:
Antisense compounds, compositions and methods are provided for modulating the expression of CD36L1. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding CD36L1. Methods of using these compounds for modulation of CD36L1 expression and for treatment of diseases associated with expression of CD36L1 are provided.
REFERENCES:
patent: 5801154 (1998-09-01), Baracchini et al.
patent: 5962322 (1999-10-01), Kozarsky et al.
patent: 5965790 (1999-10-01), Acton
patent: 6008014 (1999-12-01), Gimeno et al.
patent: 6130041 (2000-10-01), Acton
patent: 6261760 (2001-07-01), Fielding et al.
patent: WO 9911288 (1999-03-01), None
patent: WO 0077214 (2000-12-01), None
patent: WO 0234883 (2002-05-01), None
Calvo, D. et al. J. Biochem. Sep. 1993 268(25) 18929-18935.*
Branch, A. D., (1998). Trends Biochem Sci. 1998 Feb.;23(2):45-50.*
Gewirtz et al., Proc. Natl. Acad. Sci. v 93, pp. 3161-3163.*
Agrawal, S. Trends Biotechnol. Oct. 1996;14(10):376-87.*
Tamm, I. et al. The Lancet. 2001, Aug. 358: 489-497.*
Braasch, D. A. Biochemistry. Apr. 2002; 41(14): 4503-4510.*
Acton et al.,Identification of scavenger receptor SR-BI as a high density lipoprotein receptor, Science,1996, 271:518-520.
Acton et al.,The HDL receptor SR-BI: a new therapeutic target for atherosclerosis?, Mol. Med. Today,1999, 5:518-524.
Acton et al.,Expression cloning of SR-BI, a CD36-related class B scavenger receptor, J. Biol. Chem., 1994,269:21003-21009.
Buechler et al.,Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages, Biochem. Biophys. Res. Commun.,1999, 262:251-254.
Calvo et al.,The CD36, CLA-1(CD36L1), and LIMPII(CD36L2)gene family: cellular distribution, chromosomal location, and genetic evolution, Genomics,1995, 25:100-106.
Calvo et al.,Human CD36 is a high affinity receptor for the native lipoproteins HDL, LDL, and VLDL, J. Lipid Res.,1998, 39:777-788.
Calvo et al.,Identification, primary structure, and distribution of CLA-1, a novel member of the CD36/LIMPII gene family, J. Biol. Chem.,1993, 268:18929-18935.
Cao et al.,Structure and localization of the human gene encoding SR-BI/CLA-1. Evidence for transcriptional control by steroidogenic factor 1, J. Biol. Chem.,1997, 272:33068-33076.
Chinetti et al.,CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors, Circulation,2000, 101:2411-2417.
Fukasawa et al.,SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells, Exp. Cell Res.,1996, 222:246-250.
Ikemoto et al.,Identification of a PDZ-domain-containing protein that interacts with the scavenger receptor class B type I, Proc. Natl. Acad. Sci. U. S. A.,2000, 97:6538-6543.
Imachi et al.,Expression of HDL receptor, CLA-1 in human smooth-muscle cells and effect of interferon-gamma on its regulation, Horm. Metab. Res.,2001, 33:389-393.
Imachi et al.,Human scavenger receptor B1 is involved in recognition of apoptotic thymocytes by thymic nurse cells, Lab. Invest.,2000, 80:263-270.
Krieger,The"best" of cholesterols, the"worst" of cholesterols: a tale of two receptors, Proc. Natl. Acad. Sci. U. S. A.,1998, 95:4077-4080.
Liu et al.,Ribonucleic acid expression of the CLA-1 gene, a human homolog to mouse high density lipoprotein receptor SR-BI, in human adrenal tumors and cultured adrenal cells, J. Clin. Endocrinol. Metab.,1997, 82:2522-2527.
Murao et al.,Characterization of CLA-1, a human homologue of rodent scavenger receptor BI, as a receptor for high density lipoprotein and apoptotic thymocytes, J. Biol. Chem.,1997, 272:17551-17557.
Pussinen et al.,The human breast carcinoma cell line HBL-100 acquires exogenous cholesterol from high-density lipoprotein via CLA-1(CD-36 and LIMPII analogous 1)—mediated selective cholesteryl ester uptake, Biochem. J.,2000, 349:559-566.
Rigotti et al.,The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids, The Journal of BIological Chemistry,1995, 270:16221-16224.
Sehayek et al.,Biliary cholesterol excretion: a novel mechanism that regulates dietary cholesterol absorption, Proc. Natl. Acad. Sci. U. S. A.,1998, 95:10194-10199.
Stangl et al.,Transport of lipids from high and low density lipoproteins via scavenger receptor-BI, J. Biol. Chem.,1999, 274:32692-32698.
Trigatti et al.,Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology, Proc. Natl. Acad. Sci. U. S. A.,1999, 96:9322-9327.
ISIS Pharmaceuticals Inc.
LeGuyader John L.
Licata & Tyrrell P.C.
Schultz J D
LandOfFree
Antisense modulation of CD36L 1 expression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense modulation of CD36L 1 expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense modulation of CD36L 1 expression will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3501193